Navigation Links
Leading AIDS Groups Turn Up The Heat on '08 Presidential Candidates
Date:11/28/2007

will Sen. Hillary Clinton redouble efforts against global HIV/AIDS?". Voting records and public comments provide the basis for GMHC's comprehensive report and a useful "quick chart" comparing the candidates' AIDS-related public record and positions.

Some of the notable information available on AIDSVote.org and on GMHC.org:

-- The GMHC report documents, for the first time in one place, the stark

differences between Democratic and Republican presidential candidates

on nearly every AIDS issue. For example, seven Democrats have

committed to investing $50 billion to fight HIV/AIDS globally over the

next five years. No Republican candidate has made a similar

commitment. All eight Democratic candidates support comprehensive sex

education, whereas seven of eight Republicans have opposed it. Most of

the Democrats support lifting the ban against HIV-positive foreign

nationals visiting and/or immigrating to the U.S.; most Republican

candidates either support the existing ban or have not come out against

it.

-- The three leading Democratic candidates -- Sen. Barack Obama, former

Sen. John Edwards, and Sen. Hillary Clinton -- have all publicly

supported ending the ban on federal funding for needle exchange, a

scientifically proven intervention to reduce the spread of HIV without

increasing drug use. President George W. Bush and former President

Bill Clinton faced stiff criticism by public health experts for failing

to lift the ban during their terms in office.

-- For the first time, five presidential candidates -- Clinton, Edwards,

Obama, Rep. Dennis Kucinich, and Gov. Bill Richardson -- have committed

to crafting a national AIDS strategy early in their first term if

elected. The creation of a comprehensive outcomes-based national AIDS

strategy with explicit ben
'/>"/>

SOURCE Gay Men's Health Crisis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
2. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
3. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
4. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
5. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
6. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
7. Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection
8. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
9. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
10. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
Post Your Comments:
*Name:
*Comment:
*Email: